Text-message Reminders in Colorectal Cancer Screening (TRICCS): A randomised controlled trial

British Journal of Cancer

Volumn 116, Issue 11, 2017, Pages 1408-1414

  Hirst, Yasemin ^a   Skrobanski, Hanna ^a   Kerrison, Robert S ^a   Kobayashi, Lindsay C ^a,b   Counsell, Nicholas ^a   Djedovic, Natasha ^c   Ruwende, Josephine ^d   Stewart, Mark ^c   Von Wagner, Christian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

^c ST MARK S HOSPITAL   (United Kingdom)

^d NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

Cancer screening; Colorectal; Randomised controlled trial; Reminder; Text message; Uptake

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; ENGLAND; FEMALE; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOBILE PHONE; OCCULT BLOOD; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; TEXT MESSAGING; AGE; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; PATIENT COMPLIANCE; SEX FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; CELL PHONE; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; REMINDER SYSTEMS; SEX FACTORS; SOCIOECONOMIC FACTORS; TEXT MESSAGING;

EID: 85019870635     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2017.117     Document Type: Article

References (34)

1. Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, Lee JY, Cameron KA, Ferreira MR, Stephens Q, Goldman SN (2014) Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: A randomized clinical trial. JAMA Intern Med 174(8): 1235-1241.
2. Baron RC, Rimer BK, Breslow RA, Coates RJ, Kerner J, Melillo S, Habarta N, Kalra GP, Chattopadhyay S, Wilson KM, Lee NC (2008) Client-directed interventions to increase community demand for breast, cervical, colorectal cancer screening: A systematic review. Am J Prev Med 35(1): S34-S55.
3. Cancer Research UK (2016a) Bowel Cancer Incidence Statistics. Available at http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-bycancer-type/bowel-cancer/incidencelast accessed 8 November 2016.
4. Cancer Research UK (2016b) Bowel Cancer Mortality Statistics. Available at http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-bycancer-type/bowel-cancer/mortalitylast accessed 8 November 2016.
5. Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, Guasticchi G, Rossi PG (2013) Methods to increase participation in organised screening programs: A systematic review. BMC Public Health 13(1): 1.
6. Davis TC, Arnold CL, Bennett CL, Wolf MS, Reynolds C, Liu D, Rademaker A (2014) Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev 23(1): 134-143.
7. Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J (2013) Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev (12): CD007458.
8. Halloran SP (2009) Bowel cancer screening. Surgery (Oxford) 27(9): 397-400.
9. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L (2008) Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 103(6): 1541-1549.
10. Hirst Y, Kerrison R, Kobayashi LC, Counsell N, Djedovic N, Ruwende J, Stewart M, von Wagner C (2016) Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial. BMC Public Health 16(1): 74.
11. House of Commons (2014) Number of people who were eligible and who participated in the bowel cancer screening programme-England. Available at http://www.publications.parliament.uk/pa/cm201314/cmhansrd/cm140401/text/140401w0001.htm#1404026000191 (last accessed 8 November 2016).
12. Icheku V, Arowobusoye N (2015) Evaluation of a service intervention to improve uptake of breast cancer screening in a London Borough with many hard to reach communities. Univ J Public Health 3(2): 92-102.
13. iPlato (2013) iPlato, about us 2013. Available at http://www.iplato.net/aboutlast accessed 9 November 2016.
14. Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM (2010) Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting. J Gastroenterol Hepatol 25(10): 1661-1667.
15. Janz NK, Lakhani I, Vijan S, Hawley ST, Chung LK, Katz SJ (2007) Determinants of colorectal cancer screening use, attempts, non-use. Prev Med 44(5): 452-458.
16. Kaplan WA (2006) Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries Global Health 2: 9.
17. Kerrison RS, Shukla H, Cunningham D, Oyebode O, Friedman E (2015) Textmessage reminders increase uptake of routine breast screening appointments: A randomised controlled trial in a hard-to-reach population. BJC 112(6): 1005-1010.
18. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, the American College of Radiology. CA Cancer J Clin 58(3): 130-160.
19. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C (2014) Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 64(2): 282-291.
20. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C (2015a) Predictors of repeat participation in the NHS bowel cancer screening programme. BJC 112(1): 199-206.
21. Lo SH, Waller J, Vrinten C, von Wagner C (2015b) Micro actions in colorectal cancer screening participation: A population-based survey study. BMC Cancer 15(1): 438.
22. Matsumoto M, Nishimura T (1998) Mersenne twister: A 623-dimensionally equidistributed uniform pseudo-random number generator. ACM Trans Model Comput Simul 8: 3-30.
23. Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, Halloran SP (2016) Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: Results from a pilot study within the national screening programme in England. Gut; e-pub ahead of print 7 June 2016; doi:10.1136/gutjnl-2015-310691.
24. Myers RE, Sifri R, Hyslop T, Rosenthal M, Vernon SW, Cocroft J, Wolf T, Andrel J, Wender R (2007) A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer 110(9): 2083-2091.
25. Ofcom C (2016) The Communications Market Reports. Available at http://stakeholders.ofcom.org.uk/binaries/research/cmr/cmr16/uk/CMR-UK-2016.pdf (last accessed 9 November 2016).
26. Power E, Miles A, von Wagner C, Robb K, Wardle J (2009) Uptake of colorectal cancer screening: System, provider and individual factors and strategies to improve participation. Future Oncol 5(9): 1371-1388.
27. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD (2002) Effect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. Gut 50(6): 840-844.
28. Segnan N, Patnick J, Von Karsa L (Eds) (2010) European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Office for Official Publications of the European Communities European Commission
29. Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C (2015) Optimising colorectal cancer screening acceptance: A review. Gut, 64 (7) 1158-1177.
30. Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, Ng SS, Lau JY, Zheng S, Adler S, Reddy N (2015) An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 64(1): 121-132.
31. van Dam L, Korfage IJ, Kuipers EJ, Hol L, van Roon AH, Reijerink JC, van Ballegooijen M, van Leerdam ME (2013) What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy Eur J Cancer 49(10): 2321-2330.
32. van Rijn AF, van Rossum LG, Deutekom M, Laheij RJ, Fockens P, Bossuyt PM, Dekker E, Jansen JB (2008) Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. J Public Health (Oxf) 30(4): 461-465.
33. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J (2011) Inequalities in participation in an organized national colorectal cancer screening programme: Results from the first 2.6 million invitations in England. Int J Epidemiol 40(3): 712-718.
34. White B, Power E, Ciurej M, Lo SH, Nash K, Ormiston-Smith N (2015) Piloting the impact of three interventions on guaiac faecal occult blood test uptake within the NHS Bowel Cancer Screening Programme. Biomed Res Int 2015: 928251.